Browsing Tag
AbCellera Biologics Inc.
1 post
Jazz Pharmaceuticals (JAZZ) builds $4bn oncology option through AbCellera partnership
Jazz could pay AbCellera more than $4 billion across five oncology programmes. Read how the option deal reshapes JAZZ and ABCL growth strategies.